Raamdeo Agrawal

Market Veteran Raamdeo Agrawal: “When FIIs Return, Nifty Could Hit 30,000”

At the CNBC-TV18 Global Leadership Summit, Raamdeo Agrawal, Chairman and Co-founder of Motilal Oswal Financial Services, expressed confidence in the resilience of India’s markets and future potential for the Nifty index. Despite the current slowdown in earnings growth, Agrawal emphasized that this downturn is only temporary, and he expects a revival within the next six…

Read Full News
Tata Motors

Tata Motors’ New Tamil Nadu Facility to Manufacture Tata and JLR Models by 2032 Promises Job Creation and Cutting-Edge Technology

Introduction Tata Motors is taking a bold step forward with a major investment in a new manufacturing facility in Tamil Nadu, India. This advanced greenfield plant, backed by an investment of Rs 9,000 crore, will bring a significant boost to Tata’s production capacity and job creation, with 5,000 positions expected to emerge. Notably, this facility…

Read Full News
Reliance

Reliance and Nvidia Partner to Build AI Infrastructure in India: Jensen Huang

Reliance Industries and Nvidia are joining forces to build AI infrastructure in India, announced Nvidia CEO Jensen Huang on October 24. During a conversation with RIL chairman Mukesh Ambani, Huang expressed his enthusiasm for the collaboration, calling it a remarkable opportunity for India, given its large population and vast pool of computer engineers. “This is…

Read Full News
ICICI

ICICI and HDFC Bank Dominate ₹81,151 Crore Market Valuation Growth Among Top 10 Companies

Last week, the BSE benchmark fell by 156.61 points, or 0.19 percent. Among the top 10 most valuable companies, four collectively added Rs 81,151.31 crore to their market capitalization, with ICICI Bank and HDFC Bank leading the gains. While HDFC Bank, Bharti Airtel, ICICI Bank, and State Bank of India saw increases, Reliance Industries, Tata…

Read Full News
Mankind Pharma

Mankind Pharma Partners with Kotak and IIFL for Rs 3,000 Crore QIP to Fund BSV Deal

Mankind Pharma, India’s fourth-largest pharmaceutical company by domestic sales, has strategically moved forward with its Rs 13,630 crore acquisition of Bharat Serums and Vaccines (BSV). In a bold funding move, the pharma giant has partnered with Kotak Mahindra Capital and IIFL Capital to launch a Qualified Institutional Placement (QIP) worth up to Rs 3,000 crore,…

Read Full News
Invest

Karnataka’s Race for Big Projects: Overhauling Invest Karnataka Forum to Attract Investment and Generate Jobs

Karnataka is positioning itself for a major economic transformation by revamping its investment promotion agency, the Invest Karnataka Forum (IKF). With the ambitious target of becoming a $1 trillion economy by 2032 and creating 25 lakh jobs in the next five to seven years, the state is making aggressive moves to attract large-scale investments, particularly…

Read Full News
Verified by MonsterInsights